Induction of α-synuclein aggregation by intracellular nitrative insult

Journal of Neuroscience

Volumn 21, Issue 20, 2001, Pages 8053-8061

  Paxinou, Evgenia ^a   Chen, Qiping ^a   Weisse, Marie ^a   Giasson, Benoit I ^b   Norris, Erin H ^b   Rueter, Susan M ^b   Trojanowski, John Q ^b   Lee, Virginia M Y ^b   Ischiropoulos, Harry ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Nitric oxide; Parkinson's disease; Peroxynitrite; Proteasome; Superoxide; Ubiquitin; synuclein aggregation

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN ANTIBODY; AMMONIUM CHLORIDE; BETA SYNUCLEIN; DIHYDRORHODAMINE 123; NITRATE; NITRIC OXIDE; PEROXYNITRITE; PROTEASOME INHIBITOR; PROTEIN ANTIBODY; RHODAMINE 123; SUPEROXIDE; SYNUCLEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYSOSOME; MICROSCOPY; NERVE DEGENERATION; NEUROPATHY; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; STEADY STATE;

EID: 0035887860     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-20-08053.2001     Document Type: Article

References (62)

1. Kinetics of peroxynitrite reaction with amino acids and human serum albumin
2. α-synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
3. Inactivation of tyrosine hydroxylase following exposure to peroxynitrite and MPTP
4. Mechanisms of reduced striatal NMDA excitotoxicity in type 1 nitric oxide synthase knock-out mice
5. Degradation of α-synuclein by proteasome
6. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
7. Paraquat elicited neurobehavioral syndrome caused by dopaminergic cell loss
8. Coldinduced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase
9. High-efficient transfection using calcium phosphate-DNA precipitate formed in BES
10. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
11. Synergistic interaction between NADPH-cytochrome P-450 reductase, paraquat and iron in the generation of active oxygen radicals
12. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
13. Resistance to neurotoxicity in cortical neuronal cultures from neuronal nitric oxide synthase deficient mice
14. Neuropathology of synuclein aggregates
15. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
16. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neuronal damage
17. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation
18. A Drosophila model of Parkinson's disease
19. A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line
20. Diazeniumdiolates: Pro- and antioxidant applications of the "NONOates."
21. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro
22. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
23. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
24. Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases
25. Protein nitration in Parkinson's disease
26. Two distinct mechanisms of nitric oxide-mediated neuronal cell death show thiol dependency
27. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy Body disease
28. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
29. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation
30. Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat phenochromocytoma cells
31. α-synuclein promotes mitochondrial deficit and oxidative stress
32. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase
33. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species
34. Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123
35. Aggresomes: A cellular response to misfolded proteins
36. Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation
37. Sensitization of neuronal celts to oxidative stress with mutated human alpha-synuclein
38. Peroxynitrite-mediated oxidation of diydrorhodamine
39. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
40. Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult
41. Inducible nitric oxide synthase stimulates dopaminergic neruodegeneration in the MPTP model of Parkinson disease
42. Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells
43. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation: A novel mechanism of toxicity
44. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
45. Constitutive phosphorylation of the Parkinson's disease associated α-synuclein
46. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity
47. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and O,O′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease
48. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
49. Role of neuronal nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity
50. Oxidative post-translational modifications of α-synuclein in the MPTP mouse model of Parkinson's disease
51. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on the MHC class I molecules
52. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons
53. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins
54. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
55. Widespread peroxynitrite-mediated damage in Alzheimer's disease
56. Dityrosine cross-linking promotes formation of stable α-synuclein polymers
57. Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity
58. Inducible expression of mutant a-synuclein decreases proteasome activity and increases sensitivity to mitochondrial-dependent apoptosis
59. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease
60. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway
61. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochrondria
62. Neuropathology in mice expressing human α-synuclein